Cytogenetic remission induced by interferon-alpha in a myeloproliferative disorder with trisomy 8

Br J Haematol. 1996 Mar;92(4):941-3. doi: 10.1046/j.1365-2141.1996.428966.x.

Abstract

We report a case of an unusual myeloproliferative disorder with trisomy of chromosome 8 characterized by peripheral blood thrombocythaemia and pronounced bone marrow myelodysplastic features. Treatment with interferon-alpha at intermediate dosages, together with a complete bone marrow and peripheral blood haematology remission, was able to induce a cytogenetic remission, shown by the complete disappearance at the conventional cytogenetic analysis of trisomy 8 abnormality characterizing the neoplastic clone at diagnosis. However, trisomy 8 was still detectable by FISH in a small proportion of cells, showing that profound suppression of, but not complete eradication of, the neoplastic clone had occurred. The ability of interferon-alpha to induce a major cytogenetic remission in a +8, Philadelphia-chromosome negative, myeloproliferative disorder has not previously been documented and may provide further indications for the use of this drug in these disorders.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Chromosomes, Human, Pair 8*
  • Humans
  • In Situ Hybridization, Fluorescence
  • Interferon-alpha / therapeutic use*
  • Male
  • Myeloproliferative Disorders / genetics
  • Myeloproliferative Disorders / therapy*
  • Trisomy*

Substances

  • Interferon-alpha